{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": false,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETP",
        "complex_factors": [
            "Leverage (3x Daily)",
            "Integral Derivative Use (Futures)",
            "Daily Compounding Effect / Roll Costs",
            "Implied Synthetic Replication Structure",
            "Counterparty Risk",
            "Specific Investor Knowledge Required",
            "Comprehension Alert in KID"
        ],
        "classification": "complex",
        "supporting_data": "The WisdomTree EURO STOXX 50u00ae 3x Daily Leveraged ETP is classified as complex due to multiple factors, despite its UCITS eligibility. Firstly, the Key Information Document (KID) explicitly includes a comprehension alert stating, 'You are about to purchase a product that is not simple and may be difficult to understand,' which is a direct trigger for complex classification under MiFID II Rule 7. Secondly, the product provides 3 times the daily leveraged exposure to the EURO STOXX 50 EUR Net Return Index. Significant leverage is a primary indicator of complexity (MiFID II Rule 5). This leverage is achieved through the integral use of derivative instruments, specifically 'futures contracts referenced in the Benchmark', which are central to the product's investment objective rather than solely for efficient portfolio management (MiFID II Rule 2). ESMA guidelines (CESR/09-295, Paragraph 7) state that 'all derivatives are assumed to be complex'.Thirdly, the product features a 'daily reset' of its leverage factor, leading to a 'compounding effect' over periods longer than one day. This effect, combined with the mention of 'rolling' of futures contracts, implies exposure to roll costs, contango, or backwardation effects, which make the product's performance profile difficult to understand and predict for retail investors with basic knowledge (MiFID II Rule 4). Fourthly, while not explicitly stated as 'synthetic replication', the description of the product as a 'collateralised debt security' and its reliance on futures to deliver leveraged returns strongly imply a synthetic replication method. Synthetic replication introduces risks like counterparty risk and collateral risk (MiFID II Rule 3), which are difficult for retail investors to grasp. The KID highlights counterparty risk by mentioning that the 'Issuer is a special purpose company' and that investors 'may suffer a loss if you cannot realise the full value of your investment' in case of issuer default.Finally, the product's target investor is described as 'informed retail investors who... have specific knowledge or experience of investing in similar products and in financial markets', indicating that it is not designed for investors with only basic financial literacy (MiFID II Rule 4 Nuance). The highest risk indicator (7 out of 7) further underscores the high risk associated with these complex structural features."
    }
}